RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
SMXAX
Price
$18.89
Change
-$0.14 (-0.74%)
Updated
Sep 20 closing price
Ad is loading...

RPMGX vs SMXAX

Header iconRPMGX vs SMXAX Comparison
Open Charts RPMGX vs SMXAXBanner chart's image
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
SEI Extended Market Index A (SIIT)
Price$18.89
Change-$0.14 (-0.74%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPMGX vs SMXAX Comparison Chart
Loading...
VS
RPMGX vs. SMXAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMGX is a StrongBuy and SMXAX is a Buy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. SMXAX (1.16B). SMXAX pays higher dividends than RPMGX: SMXAX (1.10) vs RPMGX (0.05). RPMGX was incepted earlier than SMXAX: RPMGX (32 years) vs SMXAX (12 years). SMXAX is a more actively managed with annual turnover of: 34.00 vs. RPMGX (21.70). RPMGX has a lower initial minimum investment than SMXAX: RPMGX (2500) vs SMXAX (100000). SMXAX annual gain was more profitable for investors over the last year : 28.09 vs. RPMGX (14.65). SMXAX return over 5 years is better than : 28.07 vs. RPMGX (14.51).
RPMGXSMXAXRPMGX / SMXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years12 years-
Gain YTD9.02611.90076%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B1.16B2,709%
Annual Yield % from dividends0.051.105%
Returns for 1 year14.6528.0952%
Returns for 3 years-13.81-15.8787%
Returns for 5 years14.5128.0752%
Returns for 10 years43.2966.5565%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCTO2.610.42
+19.17%
Eightco Holdings Inc
UFI7.700.11
+1.45%
UNIFI
ALKT31.64-0.41
-1.28%
Alkami Technology
BXP81.02-1.29
-1.57%
BXP Inc.
TRDA14.69-0.31
-2.07%
Entrada Therapeutics